FLINT — Diplomat Pharmacy Inc. (NYSE: DPLO), the Flint-based specialty pharmacy, has partnered with New York City-based SMRxT Inc. to begin deploying its Nomi medication adherence system.
Nomi is a real-time, data-driven system that helps health care professionals understand and manage patients’ adherence challenges. The system captures data about how patients take medication and translates it into actionable information for clinical interventions and better patient engagement.
“One of the largest health care problems is medication nonadherence,” said Gary Rice, Diplomat executive vice president of operations. “Nomi empowers patients, guides them to healthy behavior, and prevents unnecessary health care costs. With Nomi, we can provide immediate clinical interventions and help prevent failed therapy.”
When a patient takes their medication, sensor technologies record the time and the number of tablets taken. That data is posted to the patient’s adherence record and made available to health care providers through a secure website.
With this technology, pharmacies know a patient’s precise dosing behavior and can contact them right away to resolve adherence barriers, such as side effects that deter them from continuing therapy.
Said Michael Huffer, president and CEO of SMRxT: “By joining forces, we will bring a novel adherence and persistency program to market. We’re looking forward to helping Diplomat patients achieve higher medication adherence and better health outcomes.”
For more information, visit diplomat.is or NomiAdherence.com.